Terms: = Liver cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Treatment
110 results:
1. Medicaid expansion and palliative care for advanced-stage liver cancer.
Lima HA; Mavani P; Munir MM; Endo Y; Woldesenbet S; Khan MMM; Rawicz-Pruszyński K; Waqar U; Katayama E; Resende V; Khalil M; Pawlik TM
J Gastrointest Surg; 2024 Apr; 28(4):434-441. PubMed ID: 38583893
[TBL] [Abstract] [Full Text] [Related]
2. Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host.
Zhou R; Wu ST; Yazdanifar M; Williams C; Sanders A; Brouwer C; Maher J; Mukherjee P
J Immunother; 2024 Apr; 47(3):77-88. PubMed ID: 38270462
[TBL] [Abstract] [Full Text] [Related]
3. Development of Engineered CAR T Cells Targeting Tumor-Associated Glycoforms of muc1 for the treatment of Intrahepatic Cholangiocarcinoma.
Mao L; Su S; Li J; Yu S; Gong Y; Chen C; Hu Z; Huang X
J Immunother; 2023 Apr; 46(3):89-95. PubMed ID: 36883998
[TBL] [Abstract] [Full Text] [Related]
4. The multifaceted role of muc1 in tumor therapy resistance.
Jin W; Zhang M; Dong C; Huang L; Luo Q
Clin Exp Med; 2023 Sep; 23(5):1441-1474. PubMed ID: 36564679
[TBL] [Abstract] [Full Text] [Related]
5. treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update.
Ferenci P; Reiberger T; Jachs M
Cells; 2022 Nov; 11(22):. PubMed ID: 36428959
[TBL] [Abstract] [Full Text] [Related]
6. Genetic alterations shaping tumor response to anti-EGFR therapies.
Vaquero J; Pavy A; Gonzalez-Sanchez E; Meredith M; Arbelaiz A; Fouassier L
Drug Resist Updat; 2022 Sep; 64():100863. PubMed ID: 36063655
[TBL] [Abstract] [Full Text] [Related]
7. "A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring".
Soledad Poetto A; Posocco B; Zanchetta M; Gagno S; Orleni M; Canil G; Alberti M; Puglisi F; Toffoli G
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Sep; 1207():123403. PubMed ID: 35940043
[TBL] [Abstract] [Full Text] [Related]
8. A Phase 1 study of ADI-PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1-negative metastatic uveal melanoma.
Chan PY; Phillips MM; Ellis S; Johnston A; Feng X; Arora A; Hay G; Cohen VML; Sagoo MS; Bomalaski JS; Sheaff MT; Szlosarek PW
Pigment Cell Melanoma Res; 2022 Jul; 35(4):461-470. PubMed ID: 35466524
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids.
Middelkoop MA; de Lange ME; Clark TJ; Mol BWJ; Bet PM; Huirne JAF; Hehenkamp WJK
Hum Reprod; 2022 May; 37(5):884-894. PubMed ID: 35143669
[TBL] [Abstract] [Full Text] [Related]
10. Chronic hepatitis D-What is changing?
Yardeni D; Heller T; Koh C
J Viral Hepat; 2022 Apr; 29(4):240-251. PubMed ID: 35122369
[TBL] [Abstract] [Full Text] [Related]
11. Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP-TUG1/miR-4726-5p/muc1 pathway.
Tang Q; Li X; Chen Y; Long S; Yu Y; Sheng H; Wang S; Han L; Wu W
Mol Carcinog; 2022 Apr; 61(4):417-432. PubMed ID: 35040191
[TBL] [Abstract] [Full Text] [Related]
12. treatment of hepatitis B virus infection in children and adolescents.
Stinco M; Rubino C; Trapani S; Indolfi G
World J Gastroenterol; 2021 Sep; 27(36):6053-6063. PubMed ID: 34629819
[TBL] [Abstract] [Full Text] [Related]
13. Real-world data of 14 cases of brain metastases from gestational trophoblastic neoplasia and a literature review.
Xiao P; Guo T; Luo Y; Zhang M; Yin R
Arch Gynecol Obstet; 2022 Apr; 305(4):929-935. PubMed ID: 34542678
[TBL] [Abstract] [Full Text] [Related]
14. Bulevirtide for HBV and HDV infections.
Yardeni D; Koh C
Drugs Today (Barc); 2021 Jul; 57(7):433-448. PubMed ID: 34268531
[TBL] [Abstract] [Full Text] [Related]
15. Biology of primary breast cancer in older women beyond routine biomarkers.
Parks RM; Alfarsi LH; Green AR; Cheung KL
Breast Cancer; 2021 Sep; 28(5):991-1001. PubMed ID: 34165702
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report.
Toshida K; Itoh S; Yoshizumi T; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oki E; Nakamura Y; Yoshino T; Mori M
Clin J Gastroenterol; 2021 Oct; 14(5):1459-1463. PubMed ID: 34085164
[TBL] [Abstract] [Full Text] [Related]
17. pembrolizumab
Takemura A; Matsushita Y; Tamura K; Sugiyama T; Nagata M; Otsuka A; Miyake H
In Vivo; 2021; 35(3):1889-1894. PubMed ID: 33910878
[TBL] [Abstract] [Full Text] [Related]
18. Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma.
Lasala R; Santoleri F; Romagnoli A; Musicco F; Abrate P; Costantini A
J Oncol Pharm Pract; 2022 Jun; 28(4):870-883. PubMed ID: 33847190
[TBL] [Abstract] [Full Text] [Related]
19. Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
Ekanem E; Talaulikar V
Adv Ther; 2021 Jan; 38(1):137-148. PubMed ID: 33201387
[TBL] [Abstract] [Full Text] [Related]
20. Lung metastases from intraductal papillary neoplasm of the bile duct: a case report.
Fujino R; Masuoka Y; Mashiko T; Nakano A; Hirabayashi K; Nakagohri T
World J Surg Oncol; 2020 Oct; 18(1):271. PubMed ID: 33097064
[TBL] [Abstract] [Full Text] [Related]
[Next]
